Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Bush

Showing results (431-440 of 517) with videos related to

Pageof 52
Sort By:
Scientific Reports|March 12, 2024
Evidence for disrupted copper availability in human spinal cord supports Cu<sup>II</sup>(atsm) as a treatment option for sporadic cases of ALSJames B W Hilton, Kai Kysenius, Jeffrey R Liddell, et al.
Journal of Alzheimer'S Disease : JAD|December 17, 2013
Plasma amyloid-β levels are significantly associated with a transition toward Alzheimer's disease as measured by cognitive decline and change in neocortical amyloid burdenAlan Rembach, Andrew D Watt, William J Wilson, et al.
Journal of Alzheimer'S Disease : JAD|February 19, 2010
PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analysesNoel G Faux, Craig W Ritchie, Adam Gunn, et al.
Lancet (London, England)|April 18, 2003
Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's diseaseLee E Goldstein, Julien A Muffat, Robert A Cherny, et al.
Journal of Neurochemistry|July 30, 2011
The Alzheimer's therapeutic PBT2 promotes amyloid-β degradation and GSK3 phosphorylation via a metal chaperone activityPeter J Crouch, Maria S Savva, Lin W Hung, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 31, 2016
Plasma apolipoprotein J as a potential biomarker for Alzheimer's disease: Australian Imaging, Biomarkers and Lifestyle study of agingVeer Bala Gupta, James D Doecke, Eugene Hone, et al.
Acta Neuropathologica|March 2, 2025
Evidence of COMT dysfunction in the olfactory bulb in Parkinson's diseaseLeah C Beauchamp, Laura J Ellett, Sydney M A Juan, et al.
Proteomics|April 4, 2008
Investigating copper-regulated protein expression in Menkes fibroblasts using antibody microarraysTai Du, Sharon L La Fontaine, Michael Abdo, et al.
Acta Biomaterialia|May 9, 2026
Cobalt and titanium levels in the brain are associated with Alzheimer's disease pathology but not cognition: A study of older adults with and without total joint replacementRobin Pourzal, Puja Agarwal, Sue E Leurgans, et al.
AJNR. American Journal of Neuroradiology|June 22, 2023
Investigation of Brain Iron in Niemann-Pick Type C: A 7T Quantitative Susceptibility Mapping StudyP Ravanfar, W T Syeda, R J Rushmore, et al.
Pageof 52

Showing results (431-440 of 517) with videos related to

Sort By:
Pageof 52
Scientific Reports|March 12, 2024
Evidence for disrupted copper availability in human spinal cord supports Cu<sup>II</sup>(atsm) as a treatment option for sporadic cases of ALSJames B W Hilton, Kai Kysenius, Jeffrey R Liddell, et al.
Journal of Alzheimer'S Disease : JAD|December 17, 2013
Plasma amyloid-β levels are significantly associated with a transition toward Alzheimer's disease as measured by cognitive decline and change in neocortical amyloid burdenAlan Rembach, Andrew D Watt, William J Wilson, et al.
Journal of Alzheimer'S Disease : JAD|February 19, 2010
PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analysesNoel G Faux, Craig W Ritchie, Adam Gunn, et al.
Lancet (London, England)|April 18, 2003
Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's diseaseLee E Goldstein, Julien A Muffat, Robert A Cherny, et al.
Journal of Neurochemistry|July 30, 2011
The Alzheimer's therapeutic PBT2 promotes amyloid-β degradation and GSK3 phosphorylation via a metal chaperone activityPeter J Crouch, Maria S Savva, Lin W Hung, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 31, 2016
Plasma apolipoprotein J as a potential biomarker for Alzheimer's disease: Australian Imaging, Biomarkers and Lifestyle study of agingVeer Bala Gupta, James D Doecke, Eugene Hone, et al.
Acta Neuropathologica|March 2, 2025
Evidence of COMT dysfunction in the olfactory bulb in Parkinson's diseaseLeah C Beauchamp, Laura J Ellett, Sydney M A Juan, et al.
Proteomics|April 4, 2008
Investigating copper-regulated protein expression in Menkes fibroblasts using antibody microarraysTai Du, Sharon L La Fontaine, Michael Abdo, et al.
Acta Biomaterialia|May 9, 2026
Cobalt and titanium levels in the brain are associated with Alzheimer's disease pathology but not cognition: A study of older adults with and without total joint replacementRobin Pourzal, Puja Agarwal, Sue E Leurgans, et al.
AJNR. American Journal of Neuroradiology|June 22, 2023
Investigation of Brain Iron in Niemann-Pick Type C: A 7T Quantitative Susceptibility Mapping StudyP Ravanfar, W T Syeda, R J Rushmore, et al.
Pageof 52